192 related articles for article (PubMed ID: 26268451)
1. Formulation Strategy for the Delivery of Cyclosporine A: Comparison of Two Polymeric Nanospheres.
Goyal R; Macri L; Kohn J
Sci Rep; 2015 Aug; 5():13065. PubMed ID: 26268451
[TBL] [Abstract][Full Text] [Related]
2. Comparative study of superparamagnetic iron oxide/doxorubicin co-loaded poly (lactic-co-glycolic acid) nanospheres prepared by different emulsion solvent evaporation methods.
Mosafer J; Teymouri M
Artif Cells Nanomed Biotechnol; 2018 Sep; 46(6):1146-1155. PubMed ID: 28789586
[TBL] [Abstract][Full Text] [Related]
3. A modified double-emulsion method for the preparation of daunorubicin-loaded polymeric nanoparticle with enhanced in vitro anti-tumor activity.
Liu J; Qiu Z; Wang S; Zhou L; Zhang S
Biomed Mater; 2010 Dec; 5(6):065002. PubMed ID: 20924138
[TBL] [Abstract][Full Text] [Related]
4. Comparative evaluation of cyclosporine A/HPβCD-incorporated PLGA nanoparticles for development of effective ocular preparations.
Aksungur P; Demirbilek M; Denkbaş EB; Unlü N
J Microencapsul; 2012; 29(6):605-13. PubMed ID: 22432850
[TBL] [Abstract][Full Text] [Related]
5. High loading efficiency and sustained release of siRNA encapsulated in PLGA nanoparticles: quality by design optimization and characterization.
Cun D; Jensen DK; Maltesen MJ; Bunker M; Whiteside P; Scurr D; Foged C; Nielsen HM
Eur J Pharm Biopharm; 2011 Jan; 77(1):26-35. PubMed ID: 21093589
[TBL] [Abstract][Full Text] [Related]
6. Hydrophobic ion pairing of a minocycline/Ca(2+)/AOT complex for preparation of drug-loaded PLGA nanoparticles with improved sustained release.
Holmkvist AD; Friberg A; Nilsson UJ; Schouenborg J
Int J Pharm; 2016 Feb; 499(1-2):351-357. PubMed ID: 26773599
[TBL] [Abstract][Full Text] [Related]
7. Magnetic nanoparticles and rapamycin encapsulated into polymeric nanocarriers.
Oliveira RR; Ferreira FS; Cintra ER; Branquinho LC; Bakuzis AF; Lima EM
J Biomed Nanotechnol; 2012 Apr; 8(2):193-201. PubMed ID: 22515070
[TBL] [Abstract][Full Text] [Related]
8. Drug release behavior of poly (lactic-glycolic acid) grafting from sodium alginate (ALG-g-PLGA) prepared by direct polycondensation.
Shi G; Ding Y; Zhang X; Wu L; He F; Ni C
J Biomater Sci Polym Ed; 2015; 26(16):1152-62. PubMed ID: 26255582
[TBL] [Abstract][Full Text] [Related]
9. Nanoparticles of lipid monolayer shell and biodegradable polymer core for controlled release of paclitaxel: effects of surfactants on particles size, characteristics and in vitro performance.
Liu Y; Pan J; Feng SS
Int J Pharm; 2010 Aug; 395(1-2):243-50. PubMed ID: 20472049
[TBL] [Abstract][Full Text] [Related]
10. Silicon microfluidic flow focusing devices for the production of size-controlled PLGA based drug loaded microparticles.
Keohane K; Brennan D; Galvin P; Griffin BT
Int J Pharm; 2014 Jun; 467(1-2):60-9. PubMed ID: 24680950
[TBL] [Abstract][Full Text] [Related]
11. In vitro release characteristics and cellular uptake of poly(D,L-lactic-co-glycolic acid) nanoparticles for topical delivery of antisense oligodeoxynucleotides.
Chen YS; Alany RG; Young SA; Green CR; Rupenthal ID
Drug Deliv; 2011; 18(7):493-501. PubMed ID: 21696294
[TBL] [Abstract][Full Text] [Related]
12. Vitamin E TPGS-emulsified poly(lactic-co-glycolic acid) nanoparticles for cardiovascular restenosis treatment.
Feng SS; Zeng W; Teng Lim Y; Zhao L; Yin Win K; Oakley R; Hin Teoh S; Hang Lee RC; Pan S
Nanomedicine (Lond); 2007 Jun; 2(3):333-44. PubMed ID: 17716178
[TBL] [Abstract][Full Text] [Related]
13. Understanding the quality of protein loaded PLGA nanoparticles variability by Plackett-Burman design.
Rahman Z; Zidan AS; Habib MJ; Khan MA
Int J Pharm; 2010 Apr; 389(1-2):186-94. PubMed ID: 20038446
[TBL] [Abstract][Full Text] [Related]
14. Properties of poly(lactic-co-glycolic acid) nanospheres containing protease inhibitors: camostat mesilate and nafamostat mesilate.
Yin J; Noda Y; Yotsuyanagi T
Int J Pharm; 2006 May; 314(1):46-55. PubMed ID: 16551494
[TBL] [Abstract][Full Text] [Related]
15. G-CSF loaded biodegradable PLGA nanoparticles prepared by a single oil-in-water emulsion method.
Choi SH; Park TG
Int J Pharm; 2006 Mar; 311(1-2):223-8. PubMed ID: 16423477
[TBL] [Abstract][Full Text] [Related]
16. Entrapment and release kinetics of furosemide from pegylated nanocarriers.
Youm I; Murowchick JB; Youan BB
Colloids Surf B Biointerfaces; 2012 Jun; 94():133-42. PubMed ID: 22386795
[TBL] [Abstract][Full Text] [Related]
17. Influence of microencapsulation method and peptide loading on formulation of poly(lactide-co-glycolide) insulin nanoparticles.
Kumar PS; Ramakrishna S; Saini TR; Diwan PV
Pharmazie; 2006 Jul; 61(7):613-7. PubMed ID: 16889069
[TBL] [Abstract][Full Text] [Related]
18. Formulation of porous poly(lactic-co-glycolic acid) microparticles by electrospray deposition method for controlled drug release.
Hao S; Wang Y; Wang B; Deng J; Zhu L; Cao Y
Mater Sci Eng C Mater Biol Appl; 2014 Jun; 39():113-9. PubMed ID: 24863206
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and characterization of tumor-targeted copolymer nanocarrier modified by transferrin.
Liu R; Wang Y; Li X; Bao W; Xia G; Chen W; Cheng J; Xu Y; Guo L; Chen B
Drug Des Devel Ther; 2015; 9():2705-19. PubMed ID: 26045659
[TBL] [Abstract][Full Text] [Related]
20. Formulation and evaluation of tacrolimus-loaded galactosylated Poly(lactic-co-glycolic acid) nanoparticles for liver targeting.
Mistry NP; Desai JL; Thakkar HP
J Pharm Pharmacol; 2015 Oct; 67(10):1337-48. PubMed ID: 25944126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
